Side-by-side comparison of AI visibility scores, market position, and capabilities
Fremont CA solar microinverters (NASDAQ: ENPH) at $1.33B 2024 revenue (-42% correction); IQ microinverters + IQ Battery home energy system, 53.2% gross margin, residential solar demand recovery play competing with SolarEdge.
Enphase Energy, Inc. is a Fremont, California-based energy technology company — publicly traded on NASDAQ (NASDAQ: ENPH) as an S&P 500 Information Technology component — designing, manufacturing, and selling the IQ microinverter system for residential and commercial solar photovoltaic installations, the IQ Battery home energy storage system, and the IQ EV charger through approximately 3,700 employees worldwide. Enphase pioneered the microinverter architecture — where each individual solar panel has its own dedicated DC-to-AC inverter, compared to central string inverters that connect multiple panels in series — creating a system where one shaded or underperforming panel does not reduce the output of the entire array. In Q4 2024, Enphase reported revenue of $382.7 million (53.2% non-GAAP gross margin), shipping approximately 2.01 million microinverters (878 MW DC) and 152.4 MWh of IQ Batteries, with free cash flow of $159.2 million. Full year 2024 revenue was $1.33 billion, down 42% from 2023's peak — reflecting significant headwinds from elevated interest rates suppressing residential solar financing demand, an installer channel inventory correction as distributors worked down excess microinverter stock accumulated during the 2022-2023 supply chain restock, and European market softness. CEO Badri Kothandaraman has managed the demand cycle correction while maintaining Enphase's industry-leading gross margins and strong balance sheet ($1.72 billion in cash and marketable securities at year-end 2024).
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.